FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045553710> ?p ?o ?g. }

• W2045553710 endingPage "384" @default.
• W2045553710 startingPage "377" @default.
• W2045553710 abstract "Abstract Ras signaling is important for the intracellular transduction of mitogenic stimuli from activated growth factor receptors. We have investigated 37 sporadic malignant melanomas (15 primary cutaneous melanomas and 22 melanoma metastases) and 6 melanoma cell lines for mutations in the 3 Ras genes NRAS , KRAS and HRAS . All tumors and cell lines were additionally analyzed for mutation and expression of BRAF , which encodes a Ras‐regulated serine/threonine kinase with oncogenic properties, as well as for expression of RASSF1A , which encodes a Ras‐binding protein with tumor suppressor properties. Mutational analyses identified somatic NRAS mutations in 2 primary melanomas, 4 melanoma metastases and 2 cell lines. One melanoma metastasis showed a somatic KRAS mutation whereas HRAS mutations were not detected. Eight primary melanomas, 6 melanoma metastases and 4 melanoma cell lines carried BRAF mutations affecting the known hot‐spot codon 599. None of the tumors or cell lines with BRAF mutation demonstrated NRAS or KRAS mutations. Real‐time reverse transcription‐PCR showed that 8 melanomas (3 primary tumors, 5 melanoma metastases) had reduced RASSF1A transcript levels of ≤50% relative to benign melanocytic nevi and normal skin. Three melanoma cell lines lacked detectable RASSF1A transcripts. The RASSF1A gene promoter was hypermethylated in these 3 cell lines as well as in 6 of 8 melanomas with reduced RASSF1A mRNA levels. Treatment of the cell lines with 5‐aza‐2′‐deoxycytidine and trichostatin A resulted in demethylation of the RASSF1A promoter and re‐expression of RASSF1A transcripts. Most tumors and all cell lines with RASSF1A promoter methylation additionally carried BRAF or NRAS mutations, suggesting a synergistic effect of these aberrations on melanoma growth. Taken together, 57% of the investigated melanomas and 100% of the melanoma cell lines carried mutations in either NRAS , KRAS or BRAF . In addition, 22% of the melanomas and 50% of the cell lines showed reduced RASSF1A transcript levels. Thus, alterations of Ras pathway genes are of paramount importance in the pathogenesis of sporadic melanomas. © 2004 Wiley‐Liss, Inc." @default.
• W2045553710 created "2016-06-24" @default.
• W2045553710 creator A5008819034 @default.
• W2045553710 creator A5014129073 @default.
• W2045553710 creator A5014220830 @default.
• W2045553710 creator A5016218771 @default.
• W2045553710 creator A5037531417 @default.
• W2045553710 creator A5044702507 @default.
• W2045553710 creator A5066180291 @default.
• W2045553710 date "2004-01-09" @default.
• W2045553710 modified "2023-10-11" @default.
• W2045553710 title "Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas" @default.
• W2045553710 cites W1504197144 @default.
• W2045553710 cites W1976447608 @default.
• W2045553710 cites W1985035689 @default.
• W2045553710 cites W1994465394 @default.
• W2045553710 cites W2025761890 @default.
• W2045553710 cites W2041507551 @default.
• W2045553710 cites W2043008717 @default.
• W2045553710 cites W2043680466 @default.
• W2045553710 cites W2046278818 @default.
• W2045553710 cites W2046542611 @default.
• W2045553710 cites W2047942701 @default.
• W2045553710 cites W2055614863 @default.
• W2045553710 cites W2056578809 @default.
• W2045553710 cites W2057394091 @default.
• W2045553710 cites W2060438880 @default.
• W2045553710 cites W2060573548 @default.
• W2045553710 cites W2066074044 @default.
• W2045553710 cites W2066118482 @default.
• W2045553710 cites W2070393186 @default.
• W2045553710 cites W2083695927 @default.
• W2045553710 cites W2085109666 @default.
• W2045553710 cites W2087457210 @default.
• W2045553710 cites W2087973599 @default.
• W2045553710 cites W2092029011 @default.
• W2045553710 cites W2105006863 @default.
• W2045553710 cites W2112572166 @default.
• W2045553710 cites W2113459016 @default.
• W2045553710 cites W2114811646 @default.
• W2045553710 cites W2114852376 @default.
• W2045553710 cites W2118191558 @default.
• W2045553710 cites W2129285118 @default.
• W2045553710 cites W2156858528 @default.
• W2045553710 cites W2158150128 @default.
• W2045553710 cites W2163188200 @default.
• W2045553710 doi "https://doi.org/10.1002/ijc.11722" @default.
• W2045553710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14961576" @default.
• W2045553710 hasPublicationYear "2004" @default.
• W2045553710 type Work @default.
• W2045553710 sameAs 2045553710 @default.
• W2045553710 citedByCount "124" @default.
• W2045553710 countsByYear W20455537102012 @default.
• W2045553710 countsByYear W20455537102013 @default.
• W2045553710 countsByYear W20455537102014 @default.
• W2045553710 countsByYear W20455537102015 @default.
• W2045553710 countsByYear W20455537102016 @default.
• W2045553710 countsByYear W20455537102017 @default.
• W2045553710 countsByYear W20455537102018 @default.
• W2045553710 countsByYear W20455537102019 @default.
• W2045553710 countsByYear W20455537102020 @default.
• W2045553710 countsByYear W20455537102021 @default.
• W2045553710 countsByYear W20455537102022 @default.
• W2045553710 countsByYear W20455537102023 @default.
• W2045553710 crossrefType "journal-article" @default.
• W2045553710 hasAuthorship W2045553710A5008819034 @default.
• W2045553710 hasAuthorship W2045553710A5014129073 @default.
• W2045553710 hasAuthorship W2045553710A5014220830 @default.
• W2045553710 hasAuthorship W2045553710A5016218771 @default.
• W2045553710 hasAuthorship W2045553710A5037531417 @default.
• W2045553710 hasAuthorship W2045553710A5044702507 @default.
• W2045553710 hasAuthorship W2045553710A5066180291 @default.
• W2045553710 hasBestOaLocation W20455537101 @default.
• W2045553710 hasConcept C104317684 @default.
• W2045553710 hasConcept C1167327 @default.
• W2045553710 hasConcept C121608353 @default.
• W2045553710 hasConcept C21790070 @default.
• W2045553710 hasConcept C2777658100 @default.
• W2045553710 hasConcept C2781187634 @default.
• W2045553710 hasConcept C501734568 @default.
• W2045553710 hasConcept C502942594 @default.
• W2045553710 hasConcept C54355233 @default.
• W2045553710 hasConcept C555283112 @default.
• W2045553710 hasConcept C86803240 @default.
• W2045553710 hasConceptScore W2045553710C104317684 @default.
• W2045553710 hasConceptScore W2045553710C1167327 @default.
• W2045553710 hasConceptScore W2045553710C121608353 @default.
• W2045553710 hasConceptScore W2045553710C21790070 @default.
• W2045553710 hasConceptScore W2045553710C2777658100 @default.
• W2045553710 hasConceptScore W2045553710C2781187634 @default.
• W2045553710 hasConceptScore W2045553710C501734568 @default.
• W2045553710 hasConceptScore W2045553710C502942594 @default.
• W2045553710 hasConceptScore W2045553710C54355233 @default.
• W2045553710 hasConceptScore W2045553710C555283112 @default.
• W2045553710 hasConceptScore W2045553710C86803240 @default.
• W2045553710 hasIssue "3" @default.
• W2045553710 hasLocation W20455537101 @default.
• W2045553710 hasLocation W20455537102 @default.

• next